SAN DIEGO, CA–(Marketwired – September 01, 2015) – NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will introduce its Integrated Global Alignment (iGA™) platform to select international markets at EUROSPINE 2015, which will take place September 2-4, 2015 in Copenhagen, Denmark.
iGA is a proprietary, procedurally-integrated, digital platform of specialized products designed to help surgeons achieve more precise spinal column alignment. The platform prioritizes the importance of proper alignment and its potential to impact positive patient outcomes. The iGA platform includes a collection of products, including next generation posterior fixation, anterior and posterior implants, updated neuromonitoring and computer-assisted surgical planning technology.
The suite of proprietary, procedurally-based technologies that comprise iGA are designed to enhance clinical outcomes by increasing the predictability of achieving global alignment in spinal procedures and to help the surgeon: CALCULATE alignment parameters with NuvaMap™ and Nuvaline™ preoperative planning tools; CORRECT the anterior and posterior columns with comprehensive implant solutions using real-time intraoperative assessment via NuvaMap O.R.; and CONFIRM the restoration and preservation of global sagittal alignment postoperatively, again through NuvaMap and Nuvaline.
Jason Hannon, Executive Vice President, International, said, “The expansion of iGA into the global marketplace is yet another step forward as NuVasive looks to reshape the spine market through game-changing innovation and address the next frontier in spine surgery – ALIGNMENT. We believe this new platform marks a significant advancement in the historical approach to spine surgery with revolutionary technology to help drive better patient outcomes in surgery through the global alignment of the spine with the only integrated surgical platform that allows for intraoperative reconciliation to ensure global alignment is achieved. Following on the successful launch of iGA in the U.S. earlier this year, we are pleased to expand access to our most innovative solutions as NuVasive leads the way as a clear technology disruptor in the global marketplace.”
Surgical Platform Launch and Live Demonstrations
NuVasive will display all components of its innovative and cutting-edge iGA technologies at EUROSPINE 2015. As part of this product exhibition, NuVasive will highlight iGA at the following events:
NuVasive Lunch Workshop: NuVasive will lead a two-hour lunch workshop entitled, “Integrated Global Alignment: Comprehensive Planning, Execution and Assessment in Adult Deformity.” The Company will be joined by Prof. Dr. med. Markus Quante of Germany, Prof. Claudio Lamartina of Italy and Dr. Pedro Berjano of Italy. The workshop will be held on Wednesday, September 2, 2015 from 12:00 p.m. to 2:00 p.m. local time in Room B4, M5-6 at the Bella Center in Copenhagen.
NuVasive Exhibit Stand #105: The NuVasive technical exhibit will display products that make up the iGA platform, including ReLine™, NuvaMap™, Nuvaline™, NuvaMap O.R. and Bendini®.
About NuVasive
NuVasive is an innovative global medical device company that is changing spine surgery with minimally disruptive surgical products and procedurally integrated solutions for the spine. The Company is the third largest player in the $9.0 billion global spine market. NuVasive offers a comprehensive spine portfolio of more than 90 unique products developed to improve spine surgery and patient outcomes. The Company’s principal procedural solution is its Maximum Access Surgery, or MAS, platform for lateral spine fusion. MAS was designed to provide safer, reproducible, and clinically proven outcomes, and is a highly differentiated solution with fully integrated neuromonitoring, customizable exposure and a broad offering of application-specific implants and fixation devices designed to address a variety of pathologies.
About Integrated Global Alignment
Integrated Global Alignment is a proprietary, procedurally-integrated digital platform enabling precise spinal column alignment. The multi-product suite of spine surgical devices forms a complete procedural platform and operating philosophy that centers on the critical importance of proper alignment. The launch of the iGA platform includes a suite of alignment focused offerings, such as the introduction of next generation fixation, anterior and posterior implants, updated neuromonitoring and computer-assisted rod bending and surgical planning technology. It is this combination of procedurally-based technologies that are unique to NuVasive and designed to enhance clinical outcomes by increasing the predictability of achieving global alignment in spinal procedures.
NuVasive cautions you that statements included in this news release or made during the Eurospine 2015 that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive’s results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company’s surgical products and procedures by spine surgeons, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive’s products (including the iGA™ platform), the Company’s ability to effectually manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive’s news releases and periodic filings with the Securities and Exchange Commission. NuVasive’s public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.
(Visited 5 times, 2 visits today)